Position in CUE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,117
+$13,731 QoQ
Shares Held
479
+138.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 49 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names. CUE ranks #317 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in CUE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,117 | 479 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,386 | 6,029 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,838 | 6,029 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,334 | 6,029 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $4,111 | 6,029 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $5,492 | 6,029 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $6,571 | 6,029 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $4,563 | 6,029 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $22,689 | 18,298 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $59,353 | 31,404 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $146,596 | 55,529 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $27,629 | 12,013 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $47,252 | 12,946 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $21,523 | 6,029 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $17,182 | 6,029 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $13,799 | 6,188 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $17,962 | 7,214 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $59,589 | 12,211 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $502,401 | 44,421 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $288,267 | 19,785 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $65,612 | 5,632 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $301,705 | 24,730 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $166,908 | 13,342 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $286,371 | 19,028 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $381,055 | 15,547 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $94,674 | 6,672 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||